Bdh Industries [BDH] vs Aarti Drugs [AARTIDRUGS] Detailed Stock Comparison
Bdh Industries
BSE
Loading...
Aarti Drugs
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Bdh Industries wins in 12 metrics, Aarti Drugs wins in 8 metrics, with 0 ties. Bdh Industries appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Bdh Industries | Aarti Drugs | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 17.15 | 23.59 | Bdh Industries |
| Price-to-Book Ratio | 2.31 | 3.25 | Bdh Industries |
| Debt-to-Equity Ratio | 1.43 | 44.92 | Bdh Industries |
| PEG Ratio | 38.35 | 0.37 | Aarti Drugs |
| EV/EBITDA | 10.87 | 17.02 | Bdh Industries |
| Profit Margin (TTM) | 13.84% | 7.80% | Bdh Industries |
| Operating Margin (TTM) | 10.21% | 10.11% | Bdh Industries |
| EBITDA Margin (TTM) | 10.21% | 10.11% | Bdh Industries |
| Return on Equity | 13.49% | 12.28% | Bdh Industries |
| Return on Assets (TTM) | 10.67% | 6.53% | Bdh Industries |
| Free Cash Flow (TTM) | $145.56M | $674.20M | Aarti Drugs |
| Dividend Yield | 2.98% | 0.22% | Bdh Industries |
| 1-Year Return | -25.11% | -2.04% | Aarti Drugs |
| Price-to-Sales Ratio (TTM) | 2.31 | 1.83 | Aarti Drugs |
| Enterprise Value | $1.29B | $50.34B | Aarti Drugs |
| EV/Revenue Ratio | 1.87 | 2.08 | Bdh Industries |
| Gross Profit Margin (TTM) | 35.17% | 36.77% | Aarti Drugs |
| Revenue per Share (TTM) | $120 | $265 | Aarti Drugs |
| Earnings per Share (Diluted) | $16.10 | $20.63 | Aarti Drugs |
| Beta (Stock Volatility) | 0.04 | 0.21 | Bdh Industries |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Bdh Industries vs Aarti Drugs Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Bdh Industries | -1.97% | -7.81% | 3.45% | 2.87% | -4.08% | -20.75% |
| Aarti Drugs | -0.29% | -3.86% | 1.23% | 5.23% | 18.26% | 6.84% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Bdh Industries | -25.11% | 133.78% | 210.92% | 286.69% | 968.09% | 814.24% |
| Aarti Drugs | -2.04% | 8.97% | -37.88% | 208.08% | 2,669.78% | 2,338.13% |
Performance & Financial Health Analysis: Bdh Industries vs Aarti Drugs
| Metric | BDH | AARTIDRUGS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.59B | ₹44.42B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,292 | 159,509 |
| 90 Day Avg. Volume | 3,009 | 613,674 |
| Last Close | ₹276.10 | ₹486.65 |
| 52 Week Range | ₹241.00 - ₹417.85 | ₹312.00 - ₹635.00 |
| % from 52W High | -33.92% | -23.36% |
| All-Time High | ₹417.85 (Nov 25, 2024) | ₹1,026.95 (Oct 05, 2020) |
| % from All-Time High | -33.92% | -52.61% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.06% |
| Quarterly Earnings Growth | 0.17% | 0.62% |
| Financial Health | ||
| Profit Margin (TTM) | 0.14% | 0.08% |
| Operating Margin (TTM) | 0.10% | 0.10% |
| Return on Equity (TTM) | 0.13% | 0.12% |
| Debt to Equity (MRQ) | 1.43 | 44.92 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹119.43 | ₹149.84 |
| Cash per Share (MRQ) | ₹54.12 | ₹2.48 |
| Operating Cash Flow (TTM) | ₹227.86M | ₹2.83B |
| Levered Free Cash Flow (TTM) | ₹92.73M | ₹1.68B |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.98% | 0.22% |
| Last 12-Month Dividend | ₹9.00 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Bdh Industries vs Aarti Drugs
| Metric | BDH | AARTIDRUGS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 17.15 | 23.59 |
| Forward P/E | 38.35 | 14.97 |
| PEG Ratio | 38.35 | 0.37 |
| Price to Sales (TTM) | 2.31 | 1.83 |
| Price to Book (MRQ) | 2.31 | 3.25 |
| Market Capitalization | ||
| Market Capitalization | ₹1.59B | ₹44.42B |
| Enterprise Value | ₹1.29B | ₹50.34B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.87 | 2.08 |
| Enterprise to EBITDA | 10.87 | 17.02 |
| Risk & Other Metrics | ||
| Beta | 0.04 | 0.21 |
| Book Value per Share (MRQ) | ₹119.43 | ₹149.84 |
Financial Statements Comparison: Bdh Industries vs Aarti Drugs
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BDH | AARTIDRUGS |
|---|---|---|
| Revenue/Sales | ₹178.22M | ₹6.77B |
| Cost of Goods Sold | ₹115.54M | ₹4.37B |
| Gross Profit | ₹62.67M | ₹2.40B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹28.32M | ₹784.50M |
| EBITDA | ₹36.34M | ₹951.90M |
| Pre-Tax Income | ₹34.01M | ₹711.50M |
| Income Tax | ₹9.12M | ₹83.80M |
| Net Income (Profit) | ₹24.89M | ₹627.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BDH | AARTIDRUGS |
|---|---|---|
| Cash & Equivalents | ₹311.58M | ₹45.80M |
| Total Current Assets | ₹667.49M | ₹13.38B |
| Total Current Liabilities | ₹169.17M | ₹8.37B |
| Long-Term Debt | N/A | ₹2.86B |
| Total Shareholders Equity | ₹687.62M | ₹13.69B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | N/A | ₹8.59B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BDH | AARTIDRUGS |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BDH | AARTIDRUGS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 1,292 | 159,509 |
| Average Daily Volume (90 Day) | 3,009 | 613,674 |
| Shares Outstanding | 5.76M | 91.27M |
| Float Shares | 2.21M | 35.46M |
| % Held by Insiders | 0.57% | 0.61% |
| % Held by Institutions | 0.00% | 0.11% |
Dividend Analysis & Yield Comparison: Bdh Industries vs Aarti Drugs
| Metric | BDH | AARTIDRUGS |
|---|---|---|
| Last 12-Month Dividend | ₹9.00 | ₹1.00 |
| Last 12-Month Dividend Yield | 2.98% | 0.22% |
| 3-Year Avg Annual Dividend | ₹5.53 | ₹1.00 |
| 3-Year Avg Dividend Yield | 1.92% | 0.23% |
| 3-Year Total Dividends | ₹16.60 | ₹3.00 |
| Ex-Dividend Date | Aug 01, 2025 | Feb 04, 2025 |